The Art of Ophthalmology Medicine: Individualizing Therapy in Neovascular Age Related Macular Degeneration in an Era of Expanded Treatment Options; nAMD Day in the Life

Target Audience
This initiative is designed to meet the educational needs of retina/ophthalmology, optometry, managed care, primary care/internal medicine, diabetes education, and cardiology/endocrinology sub-specialties.

Program Overview
This enduring activity focuses on individualizing therapy for the treatment of neovascular age-related macular degeneration (nAMD). Providers will learn about the safety, efficacy, and durability of established and emerging nAMD therapies, as well as technological updates that can be used to facilitate patient screening, monitoring, and treatment interval decision-making. This activity uses a unique documentary approach to share a patient story, along with commentary from a retinal disease expert.

Learning Objectives
Upon completion of this activity, participants should be better able to:

Discuss the benefits and treatment burdens of conventional anti-VEGF therapies for patients with retinal vascular disease.
Personalize treatment and dosing strategies for patients with nAMD based patient-, disease-, and treatment-related factors.